Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
EBITDA Over TimeContracting
Percentile Rank27
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-30.37M
↓ 14% vs avg
Percentile
P27
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-26.55M
Historical baseline
PeriodValueYoY Change
TTM$-30.37M+26.1%
2024$-41.11M+37.2%
2023$-65.45M-81.5%
2022$-36.05M-64.5%
2021$-21.92M-7.3%
2020$-20.44M-18.9%
2019$-17.20M-80.3%
2018$-9.54M+4.4%
2017$-9.98M+25.9%
2016$-13.46M-